Akkermansia muciniphila isolated from forest musk deer ameliorates diarrhea in mice via modification of gut microbiota

Abstract

Background: The forest musk deer, a rare fauna species found in China, is famous for its musk secretion which is used in selected Traditional Chinese medicines. However, over-hunting has led to musk deer becoming an endangered species, and their survival is also greatly challenged by various high incidence and high mortality respiratory and intestinal diseases such as septic pneumonia and enteritis. Accumulating evidence has demonstrated that Akkermannia muciniphila (AKK) is a promising probiotic, and we wondered whether AKK could be used as a food additive in animal breeding programmes to help prevent intestinal diseases.

Methods: We isolated one AKK strain from musk deer feces (AKK-D) using an improved enrichment medium combined with real-time PCR. After confirmation by 16S rRNA gene sequencing, a series of in vitro tests was conducted to evaluate the probiotic effects of AKK-D by assessing its reproductive capability, simulated gastrointestinal fluid tolerance, acid and bile salt resistance, self-aggregation ability, hydrophobicity, antibiotic sensitivity, hemolysis, harmful metabolite production, biofilm formation ability, and bacterial adhesion to gastrointestinal mucosa.

Results: The AKK-D strain has a probiotic function similar to that of the standard strain in humans (AKK-H). An in vivo study found that AKK-D significantly ameliorated symptoms in the enterotoxigenic Escherichia coli (ETEC)-induced murine diarrhea model. AKK-D improved organ damage, inhibited inflammatory responses, and improved intestinal barrier permeability. Additionally, AKK-D promoted the reconstitution and maintenance of the homeostasis of gut microflora, as indicated by the fact that AKK-D-treated mice showed a decrease in Bacteroidetes and an increase in the proportion of other beneficial bacteria like Muribaculaceae, Muribaculum, and unclassified f_Lachnospiaceae compared with the diarrhea model mice.

Conclusion: Taken together, our data show that this novel AKK-D strain might be a potential probiotic for use in musk deer breeding, although further extensive systematic research is still needed.

Keywords

Akkermansia muciniphila / diarrhea / enterotoxigenic Escherichia coli / forest musk deer / gut microbiota

References

[1] TH Hawkins. Musk and the Musk Deer. CABI digital library; 1950.

[2] Xiuxiang M, Caiquan Z, Jinchu H, et al. Musk deer farming in China. Anim Sci. 2007;82(1):1-6.

[3] Yang Q, Meng X, Xia L, Feng Z. Conservation status and causes of decline of musk deer (Moschus spp.) in China 2003.

[4] Shrestha MN. Animal welfare in the musk deer. 1998.

[5] Fan Z, Li W, Jin J, et al. The draft genome sequence of forest musk deer (Moschus berezovskii). GigaScience. 2018;7(4):giy038.

[6] Jiang F, Zhang J, Gao H, et al. Musk deer (Moschus spp.) face redistribution to higher elevations and latitudes under climate change in China. Sci Total Environ. 2020;704:135335.

[7] Wang Y, Sun M, Chang F, et al. The essential differences in microbial and chemical components of musk of different qualities secreted by captive male forest musk deer (Moschus berezovskii). Microb Biotechnol. 2022;15(6):1783-1794.

[8] Liu X, Zhao W, Yu D, et al. Effects of compound probiotics on the weight, immunity performance and fecal microbiota of forest musk deer. Sci Rep. 2019;9(1):19146.

[9] Vicente J, Wolfenden A, Torres-Rodriguez A, Higgins S, Tellez G, Hargis B. Effect of a Lactobacillus species-based probiotic and dietary lactose prebiotic on Turkey Poult performance with or without Salmonella Enteritidis challenge. J Appl Poult Res. 2007;16(3):361-364.

[10] Zhai Q, Feng S, Arjan N, Chen W. A next generation probiotic, Akkermansia muciniphila. Crit Rev Food Sci Nutr. 2019;59(19):3227-3236.

[11] Chassard C, Delmas E, Lawson PA, Bernalier-Donadille A. bacteroides xylanisolvens sp. nov., a xylan-degrading bacterium isolated from human faeces. Int J Syst Evol Microbiol. 2008;58(4):1008-1013.

[12] Ulsemer P, Toutounian K, Schmidt J, Karsten U, Goletz S. Preliminary safety evaluation of a new bacteroides xylanisolvens isolate. Appl Environ Microbiol. 2012;78(2):528-535.

[13] Valdés-Varela L, Hernández-Barranco AM, Ruas-Madiedo P, Gueimonde M. Effect of Bifidobacterium upon Clostridium difficile growth and toxicity when co-cultured in different prebiotic substrates. Front Microbiol. 2016;7:738.

[14] Roychowdhury S, Cadnum J, Glueck B, Obrenovich M, Donskey C, Cresci GAM. Faecalibacterium prausnitzii and a prebiotic protect intestinal health in a mouse model of antibiotic and Clostridium difficile exposure. J Parenter Enter Nutr. 2018;42(7):1156-1167.

[15] Yue C, Chu C, Zhao J, Zhang H, Chen W, Zhai Q. Dietary strategies to promote the abundance of intestinal Akkermansia muciniphila, a focus on the effect of plant extracts. J Funct Foods. 2022;93:105093.

[16] Yu F, Guo J, Hl R, et al. Tyrosol inhibits NF-κB pathway in the treatment of enterotoxigenic Escherichia coli-induced diarrhea in mice. Microb Pathog. 2023;176:176.

[17] Guo X, Zhang J, Wu F, Zhang M, Yi M, Peng Y. Different subtype strains of abundantly colonize in southern China. J Appl Microbiol. 2016;120(2):452-459.

[18] Tulumoglu S, Yuksekdag ZN, Beyatli Y, Simsek O, Cinar B, Yaşar E. Probiotic properties of lactobacilli species isolated from children’s feces. Anaerobe. 2013;24:36-42.

[19] Talib N, Mohamad NE, Yeap SK, et al. Isolation and characterization of Lactobacillus spp. from kefir samples in Malaysia. Molecules. 2019;24(14):2606.

[20] Jamyuang C, Phoonlapdacha P, Chongviriyaphan N, Chanput W, Nitisinprasert S, Nakphaichit M. Characterization and probiotic properties of lactobacilli from human breast milk. 3 Biotech. 2019;9(11):398.

[21] Yasmin I, Saeed M, Khan WA, et al. In vitro probiotic potential and safety evaluation (hemolytic, cytotoxic activity) of Bifidobacterium strains isolated from raw camel milk. Microorganisms. 2020;8(3):354.

[22] Collado MC, Meriluoto J, Salminen S. Adhesion and aggregation properties of probiotic and pathogen strains. Eur Food Res Technol. 2007;226(5):1065-1073.

[23] Cozzolino A, Vergalito F, Tremonte P, et al. Preliminary evaluation of the safety and probiotic potential of Akkermansia muciniphila DSM 22959 in comparison with Lactobacillus rhamnosus GG. Microorganisms. 2020;8(2):189.

[24] Srdjan Stepanovic DV, Dakic I, Savic B, Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. 1999.

[25] Xu H, Jeong HS, Lee HY, Ahn J. Assessment of cell surface properties and adhesion potential of selected probiotic strains. Lett Appl Microbiol. 2009;49(4):434-442.

[26] Qian Z, Zhao D, Yin Y, Zhu H, Chen D. Antibacterial activity of Lactobacillus strains isolated from Mongolian yogurt against Gardnerella vaginalis. Biomed Res Int. 2020;2020:3548618.

[27] Shokryazdan P, Jahromi MF, Liang JB, et al. In vitro assessment of bioactivities of lactobacillus strains as potential probiotics for humans and chickens. J Food Sci. 2017;82(11):2734-2745.

[28] Xu B, Yan Y, Huang J, Yin B, Pan Y, Ma L. Cortex Phellodendri extract’s anti-diarrhea effect in mice related to its modification of gut microbiota. Biomed Pharmacother. 2020;123:109720.

[29] Borenshtein D, Schlieper KA, Rickman BH, et al. Decreased expression of colonic Slc26a3 and carbonic anhydrase iv as a cause of fatal infectious diarrhea in mice. Infect Immun. 2009;77(9):3639-3650.

[30] Woo H, Okamoto S, Guiney D, Gunn JS, Fierer J. A model of Salmonella colitis with features of diarrhea in SLC11A1 wild-type mice. PLoS One. 2008;3(2):e1603.

[31] Chen S, Qian K, Zhang G, Zhang M. Akkermansia muciniphila and its outer membrane protein Amuc_1100 prophylactically attenuate 5-fluorouracil-induced intestinal mucositis. Biochem Biophys Res Commun. 2022;23(614):34-40.

[32] Shi M, Yue Y, Ma C, Dong L, Chen F. Pasteurized Akkermansia muciniphila ameliorate the LPS-induced intestinal barrier dysfunction via modulating AMPK and NF-kappaB through TLR2 in Caco-2 cells. Nutrients. 2022;14(4):764.

[33] Liu J, Liu H, Liu H, et al. Live and pasteurized Akkermansia muciniphila decrease susceptibility to Salmonella Typhimurium infection in mice. J Adv Res. 2023;52:89-102.

[34] Liu Y, Liu Q, Zhang C, et al. Strain-specific effects of Akkermansia muciniphila on the regulation of intestinal barrier. Food Sci Human Wellness. 2023;12(5):1526-1537.

[35] Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54(Pt 5):1469-1476.

[36] Plovier H, Everard A, Druart C, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23(1):107-113.

[37] Roeselers G, Mittge EK, Stephens WZ, et al. Evidence for a core gut microbiota in the zebrafish. ISME J. 2011;5(10):1595-1608.

RIGHTS & PERMISSIONS

2024 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.